Research

Clinical research casebook

We track 18 clinical studies relevant to GLP-1 treatment decisions, each summarised with its own primary-source citation, results, adverse events, and limitations. Only 0 of 18 currently have enough extracted, genuinely distinct content to clear our own indexability floor; the rest are still real pages, just not yet submitted to search or AI engines.

Short answer: every study below links to its own page with the registry ID (when available), sponsor, design, population, results, and limitations, plus a direct link to the registry record and the peer-reviewed publication. Evidence status on each is Primary source linked — meaning the source is citable and authoritative, not that GLP Ranked has independently reproduced every number. See our evidence policy for what that distinction means.

All studies

StudyQuestionSponsorIndexed?
ATTAIN-1Orforglipron for chronic weight managementEli Lilly and CompanyNot yet — below word floor
Body-composition analysesLean mass change during tirzepatide treatmentNot statedNot yet — below word floor
OASIS 4Oral semaglutide 25 mg for weight managementNovo NordiskNot yet — below word floor
PCOS evidence baseTirzepatide in polycystic ovary syndromeNot statedNot yet — below word floor
Renal outcome analysesKidney endpoints with tirzepatideNot statedNot yet — below word floor
Retatrutide (TRIUMPH programme)Retatrutide phase 3 resultsEli Lilly and CompanyNot yet — below word floor
SUMMITTirzepatide in heart failure with preserved ejection fraction and obesityEli Lilly and CompanyNot yet — below word floor
SURMOUNT-1Tirzepatide in adults with obesity or overweightEli Lilly and CompanyNot yet — below word floor
SURMOUNT-1, three-year prediabetes analysisProgression to type 2 diabetesEli Lilly and CompanyNot yet — below word floor
SURMOUNT-3Tirzepatide after intensive lifestyle interventionEli Lilly and CompanyNot yet — below word floor
SURMOUNT-4Continued tirzepatide versus withdrawal for weight maintenanceEli Lilly and CompanyNot yet — below word floor
SURMOUNT-5Tirzepatide versus semaglutide, head to headEli Lilly and CompanyNot yet — below word floor
SURMOUNT-OSATirzepatide in obstructive sleep apnoea with obesityEli Lilly and CompanyNot yet — below word floor
SURPASS programmeGlycaemic outcomes with tirzepatideNot statedNot yet — below word floor
SURPASS-2Tirzepatide versus semaglutide in type 2 diabetesEli Lilly and CompanyNot yet — below word floor
SURPASS-CVOTCardiovascular outcomes with tirzepatideEli Lilly and CompanyNot yet — below word floor
SYNERGY-NASHTirzepatide in MASH with fibrosisNot statedNot yet — below word floor
SYNERGY-NASHTirzepatide for MASH with liver fibrosisEli Lilly and CompanyNot yet — below word floor

Cite this page

GLP Ranked. "Clinical research casebook." Updated 2026-07-24. https://glpranked.com/research/

GLP Ranked. "Clinical research casebook." Updated 2026-07-24. https://glpranked.com/research/